longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Tempest Therapeutics

TPST

1.04014.05% ( -0.170 )
Trading: Sep 17, 09:34:56 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.49, within the reasonable range, cheaper than 26.86% of the time in the past 5 years, and the industry ranks 131/601, the industry Median -2.34.

-0.494xP/E
$1.21Stock price
$-2.45Earnings per share
-0.494xP/E
Stock price$1.21Earnings per share$-2.45

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.74x
Typical range
-1.45x–-0.42x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
019385776

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-56.52x148.77%$183.12B
CSLLYUSCSL Limited
-22.88x--$59.00B
MRNAUSModerna
-18.45x15.47%$58.14B
NTRAUSNatera
-258.80x10.38%$49.78B
RVMDUSRevolution Medicines
-23.75x64.29%$41.99B
ROIVUSRoivant Sciences
-107.35x145.04%$28.58B
INSMUSInsmed
-30.58x74.48%$26.77B
BNTXUSBioNTech SE
-12.30x19.17%$24.07B
SMMTUSSummit Therapeutics
-16.12x18.58%$13.80B
BBIOUSBridgebio Pharma
-19.30x28.57%$13.35B
MDGLUSMadrigal Pharma
-37.60x50.86%$12.22B
KYMRUSKymera Therapeutics
-32.29x4.94%$9.67B
CYTKUSCytokinetics
-10.79x6.37%$9.65B
TWSTUSTwist Bioscience
-68.89x24.61%$9.42B
ARWRUSArrowHead Pharma
-29.05x36,308.30%$9.29B
ABVXUSAbivax SA
-22.96x32.59%$8.91B
PCVXUSVaxcyte
-8.22x48.80%$8.75B
PRAXUSPraxis Precision Medicines
-25.44x3.05%$8.63B
IBRXUSImmunityBio
-8.45x152.63%$8.38B
SYREUSSpyre Therapeutics
-53.52x47.81%$8.04B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.